Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 178,000 | 220,000 | 163,000 | 75,000 | 292,000 |
| Depreciation Amortization | 28,000 | 20,000 | 13,000 | 7,000 | 40,000 |
| Accounts receivable | 79,000 | 86,000 | 75,000 | 75,000 | -33,000 |
| Accounts payable and accrued liabilities | -101,000 | -195,000 | -167,000 | -60,000 | 58,000 |
| Other Working Capital | -79,000 | -155,000 | -131,000 | 22,000 | 29,000 |
| Other Operating Activity | 46,000 | 135,000 | 119,000 | 16,000 | -83,000 |
| Operating Cash Flow | $151,000 | $111,000 | $72,000 | $135,000 | $303,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,000 | -3,000 | -2,000 | -2,000 | -11,000 |
| Purchase Sale Intangibles | 4,000 | N/A | N/A | N/A | 7,000 |
| Other Investing Activity | 5,000 | 0 | 0 | 0 | 7,000 |
| Investing Cash Flow | $-2,000 | $-3,000 | $-2,000 | $-2,000 | $-4,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,000 | -3,000 | -2,000 | -1,000 | -240,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 3,000 |
| Other Financing Activity | -9,000 | -6,000 | -4,000 | -2,000 | 0 |
| Financing Cash Flow | $-13,000 | $-9,000 | $-6,000 | $-3,000 | $-237,000 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -1,000 |
| Beginning Cash Position | 924,000 | 924,000 | 924,000 | 924,000 | 863,000 |
| End Cash Position | 1,060,000 | 1,023,000 | 988,000 | 1,054,000 | 924,000 |
| Net Cash Flow | $136,000 | $99,000 | $64,000 | $130,000 | $61,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 151,000 | 111,000 | 72,000 | 135,000 | 303,000 |
| Capital Expenditure | -7,000 | -3,000 | -2,000 | -2,000 | -11,000 |
| Free Cash Flow | 144,000 | 108,000 | 70,000 | 133,000 | 292,000 |